Joon Lee analyst TRUIST

Currently out of the existing stock ratings of Joon Lee, 222 are a BUY (89.16%), 27 are a HOLD (10.84%).

Joon Lee

Work Performance Price Targets & Ratings Chart

Analyst Joon Lee, currently employed at TRUIST, has had 51.44% of price targets met with an average potential upside of 63.23%, reached in 268 days on average.

Joon Lee has documented 489 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 11-Mar-2026.

Wall Street Analyst Joon Lee

Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) on 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%), with a performance score of 159.54.

Average potential price target upside

ADVM Adverum Biotechnologies ALKS Alkermes Plc ARGX argenx NV ADR ARVN Arvinas AXSM Axsome Therapeutics BMRN Biomarin Pharmaceutical CNCE Concert Pharmaceuticals CORT Corcept Therapeutics CPRX Catalyst Pharmaceuticals CRMD CorMedix CRSP Crispr Therapeutics AG EDIT Editas Medicine GBT Global Blood Therapeutics JAZZ Jazz Pharmaceuticals PLC LBPH Longboard Pharmaceuticals LJPC La Jolla Pharmaceutical Co LRMR Larimar Therapeutics NTLA Intellia Therapeutics PRAX Praxis Precision Medicines PTCT PTC Therapeutics SAGE Sage Therapeutic VKTX Viking Therapeutics VRNA Verona Pharma PLC ADR VRTX Vertex Pharmaceuticals VYGR Voyager Therapeutics WVE Wave Life Sciences Ltd ANAB AnaptysBio RARE Ultragenyx RLMD Relmada Therapeutics TSHA Taysha Gene Therapies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Apr-2024

$5

1 years 1 days ago
(17-Nov-2025)

0/6 (0%)

$0.73 (17.10%)

Buy Since 28-Apr-2020

$5.5

$12

1 years 20 days ago
(29-Oct-2025)

1/8 (12.5%)

$1.27 (30.02%)

366

Hold Since 16-Apr-2025

$4

$5

1 years 21 days ago
(28-Oct-2025)

1/2 (50%)

$-0.26 (-6.10%)

168

Buy Since 18-Jul-2024

1 years 3 months 5 days ago
(13-Aug-2025)

0/2 (0%)

$30.52 (321.94%)

Hold Since 11-Nov-2022

$4

$5

1 years 6 months 3 days ago
(15-May-2025)

4/9 (44.44%)

$1.95 (95.12%)

102

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Joon Lee?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?